Article citationsMore>>

Cheng, S.T., et al. (2016) The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic Beta-Cell Mass and Glucose Homeostasis in Type 1 Diabetes. PLoS ONE, 11, e0147391.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.